Belzutifan (Welireg)

Status:

Red

Decision Date:

November 2024

Comments

RED: NICE TA1011 - Belzutifan for treating tumours associated with von Hippel-Lindau disease (Decision date November 2024)

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again